Investing.com - Morphosys AG reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Morphosys AG announced earnings per share of €-3.3 on revenue of €38.8M. Analysts polled by Investing.com anticipated EPS of €-2.85 on revenue of €39.58M.
Morphosys AG shares are up 50% from the beginning of the year and are trading at €35.970 , down-from-52-week-high.They are outperforming the PSI 20 which is up 15.69% from the start of the year.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings missed by Siemens Healthineers on Thursday, November 4, 2021, who reported EPS of €0.53 on revenue of €5.16B, compared to forecasts EPS of €0.585 on revenue of €4.89B.
Bayer had beat expectations on Tuesday with third quarter EPS of €1.05 on revenue of €9.78B, compared to forecast for EPS of €0.8831 on revenue of €9.21B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar